INT MEDICAL (01501) Income Statement & Earnings

38.660
-0.060-0.15%

Trading Apr 27 11:52 CST

8.16BMarket Cap33.71P/E (TTM)

INT MEDICAL (01501) Income Statement

All

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q6)Jun 30, 2025

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

Turnover

25.06%1.07B

17.52%461.08M

13.17%851.95M

15.47%392.32M

28.50%752.84M

50.86%339.76M

26.08%585.88M

24.70%225.22M

29.64%464.68M

5.10%180.61M

Operating income

25.06%1.07B

17.52%461.08M

13.17%851.95M

15.47%392.32M

28.50%752.84M

50.86%339.76M

26.08%585.88M

24.70%225.22M

29.64%464.68M

5.10%180.61M

Cost of sales

-36.40%-428.69M

-30.82%-190.41M

0.15%-314.29M

-4.40%-145.55M

-24.22%-314.77M

-37.77%-139.41M

-34.12%-253.4M

-56.46%-101.19M

-52.35%-188.93M

-11.47%-64.68M

Operating expenses

-36.40%-428.69M

-30.82%-190.41M

0.15%-314.29M

-4.40%-145.55M

-24.22%-314.77M

-37.77%-139.41M

-34.12%-253.4M

-56.46%-101.19M

-52.35%-188.93M

-11.47%-64.68M

Gross profit

18.44%636.79M

9.68%270.66M

22.73%537.66M

23.17%246.77M

31.76%438.07M

61.54%200.35M

20.58%332.49M

6.98%124.02M

17.63%275.75M

1.86%115.94M

Selling expenses

-47.07%-116.76M

-23.57%-41.53M

-17.79%-79.39M

-1.77%-33.61M

-19.51%-67.4M

-52.00%-33.02M

-87.85%-56.39M

-61.89%-21.72M

-39.79%-30.02M

-5.19%-13.42M

Administrative expenses

-23.54%-149.29M

-17.56%-64.92M

-21.54%-120.84M

-51.75%-55.22M

-54.65%-99.43M

-28.17%-36.39M

-31.07%-64.29M

-37.16%-28.39M

-36.38%-49.05M

-8.48%-20.7M

Research and development expenses

-0.62%-150.06M

0.73%-70.24M

-18.50%-149.13M

-9.54%-70.75M

-26.31%-125.85M

-70.30%-64.59M

-10.76%-99.63M

15.83%-37.93M

-39.26%-89.96M

-49.10%-45.06M

Impairment and provision

-66.56%209K

-136.66%-239K

253.56%625K

35.55%652K

56.00%-407K

175.51%481K

-63.14%-925K

-2,023.33%-637K

-1,388.64%-567K

-130.77%-30K

-Other impairment is provision

-66.56%209K

-136.66%-239K

253.56%625K

35.55%652K

56.00%-407K

175.51%481K

-63.14%-925K

-2,023.33%-637K

-1,388.64%-567K

-130.77%-30K

Special items of operating profit

85.29%50.56M

27.26%30.47M

-18.13%27.29M

5.03%23.94M

-2.09%33.33M

4.51%22.79M

-32.15%34.04M

-7.00%21.81M

102.70%50.17M

-5.50%23.45M

Operating profit

25.55%271.45M

11.12%124.21M

21.25%216.21M

24.72%111.78M

22.74%178.32M

56.82%89.62M

-7.06%145.29M

-5.03%57.15M

13.96%156.32M

-21.40%60.18M

Financing cost

-416.21%-12.54M

-182.46%-2.92M

23.92%-2.43M

14.36%-1.03M

-290.46%-3.19M

-274.22%-1.21M

-29.23%-818K

-2.22%-322K

-588.04%-633K

-556.25%-315K

Share of profits of associates

-48.10%-585K

---585K

---395K

----

Earning before tax

21.06%258.32M

8.99%120.71M

21.84%213.38M

25.26%110.75M

21.22%175.13M

55.58%88.42M

-7.21%144.47M

-5.07%56.83M

13.57%155.69M

-21.77%59.86M

Tax

-9.91%-25.65M

-57.90%-18.27M

-6.55%-23.34M

-46.25%-11.57M

-105.92%-21.9M

-18.02%-7.91M

30.24%-10.64M

21.77%-6.7M

25.88%-15.25M

27.48%-8.57M

After-tax profit from continuing operations

22.43%232.67M

3.29%102.44M

24.03%190.05M

23.19%99.18M

14.49%153.23M

60.61%80.51M

-4.71%133.83M

-2.28%50.13M

20.54%140.45M

-20.72%51.29M

Earning after tax

22.43%232.67M

3.29%102.44M

24.03%190.05M

23.19%99.18M

14.49%153.23M

60.61%80.51M

-4.71%133.83M

-2.28%50.13M

20.54%140.45M

-20.72%51.29M

Minority profit

844.66%13.89M

387.35%3.91M

42.24%-1.87M

-45,433.33%-1.36M

-252.31%-3.23M

100.42%3K

184.29%2.12M

-203.92%-716K

48.00%-2.52M

125.59%689K

Profit attributable to shareholders

14.00%218.79M

-2.00%98.53M

22.66%191.91M

24.89%100.54M

18.79%156.46M

58.34%80.5M

-7.87%131.71M

0.47%50.84M

17.80%142.96M

-24.91%50.61M

Basic earnings per share

14.55%1.26

-1.72%0.57

19.57%1.1

20.83%0.58

16.46%0.92

54.84%0.48

-8.14%0.79

3.33%0.31

17.81%0.86

-26.83%0.3

Diluted earnings per share

14.55%1.26

-1.72%0.57

19.57%1.1

23.40%0.58

17.95%0.92

56.67%0.47

-9.30%0.78

0.00%0.3

17.81%0.86

-26.83%0.3

Currency Unit

CNY

Accounting Standards

HKAS

Audit Opinions

Unqualified Opinion

Auditor

KPMG Huazhen Certified Public Accountants (Special General Partnership)

Lixin Certified Public Accountants (Special General Partnership)

	(FY)Dec 31, 2025	(Q6)Jun 30, 2025	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021
Turnover	25.06%1.07B	17.52%461.08M	13.17%851.95M	15.47%392.32M	28.50%752.84M	50.86%339.76M	26.08%585.88M	24.70%225.22M	29.64%464.68M	5.10%180.61M
Operating income	25.06%1.07B	17.52%461.08M	13.17%851.95M	15.47%392.32M	28.50%752.84M	50.86%339.76M	26.08%585.88M	24.70%225.22M	29.64%464.68M	5.10%180.61M
Cost of sales	-36.40%-428.69M	-30.82%-190.41M	0.15%-314.29M	-4.40%-145.55M	-24.22%-314.77M	-37.77%-139.41M	-34.12%-253.4M	-56.46%-101.19M	-52.35%-188.93M	-11.47%-64.68M
Operating expenses	-36.40%-428.69M	-30.82%-190.41M	0.15%-314.29M	-4.40%-145.55M	-24.22%-314.77M	-37.77%-139.41M	-34.12%-253.4M	-56.46%-101.19M	-52.35%-188.93M	-11.47%-64.68M
Gross profit	18.44%636.79M	9.68%270.66M	22.73%537.66M	23.17%246.77M	31.76%438.07M	61.54%200.35M	20.58%332.49M	6.98%124.02M	17.63%275.75M	1.86%115.94M
Selling expenses	-47.07%-116.76M	-23.57%-41.53M	-17.79%-79.39M	-1.77%-33.61M	-19.51%-67.4M	-52.00%-33.02M	-87.85%-56.39M	-61.89%-21.72M	-39.79%-30.02M	-5.19%-13.42M
Administrative expenses	-23.54%-149.29M	-17.56%-64.92M	-21.54%-120.84M	-51.75%-55.22M	-54.65%-99.43M	-28.17%-36.39M	-31.07%-64.29M	-37.16%-28.39M	-36.38%-49.05M	-8.48%-20.7M
Research and development expenses	-0.62%-150.06M	0.73%-70.24M	-18.50%-149.13M	-9.54%-70.75M	-26.31%-125.85M	-70.30%-64.59M	-10.76%-99.63M	15.83%-37.93M	-39.26%-89.96M	-49.10%-45.06M
Impairment and provision	-66.56%209K	-136.66%-239K	253.56%625K	35.55%652K	56.00%-407K	175.51%481K	-63.14%-925K	-2,023.33%-637K	-1,388.64%-567K	-130.77%-30K
-Other impairment is provision	-66.56%209K	-136.66%-239K	253.56%625K	35.55%652K	56.00%-407K	175.51%481K	-63.14%-925K	-2,023.33%-637K	-1,388.64%-567K	-130.77%-30K
Special items of operating profit	85.29%50.56M	27.26%30.47M	-18.13%27.29M	5.03%23.94M	-2.09%33.33M	4.51%22.79M	-32.15%34.04M	-7.00%21.81M	102.70%50.17M	-5.50%23.45M
Operating profit	25.55%271.45M	11.12%124.21M	21.25%216.21M	24.72%111.78M	22.74%178.32M	56.82%89.62M	-7.06%145.29M	-5.03%57.15M	13.96%156.32M	-21.40%60.18M
Financing cost	-416.21%-12.54M	-182.46%-2.92M	23.92%-2.43M	14.36%-1.03M	-290.46%-3.19M	-274.22%-1.21M	-29.23%-818K	-2.22%-322K	-588.04%-633K	-556.25%-315K
Share of profits of associates	-48.10%-585K	---585K	---395K	----	----	----	----	----	----	----
Earning before tax	21.06%258.32M	8.99%120.71M	21.84%213.38M	25.26%110.75M	21.22%175.13M	55.58%88.42M	-7.21%144.47M	-5.07%56.83M	13.57%155.69M	-21.77%59.86M
Tax	-9.91%-25.65M	-57.90%-18.27M	-6.55%-23.34M	-46.25%-11.57M	-105.92%-21.9M	-18.02%-7.91M	30.24%-10.64M	21.77%-6.7M	25.88%-15.25M	27.48%-8.57M
After-tax profit from continuing operations	22.43%232.67M	3.29%102.44M	24.03%190.05M	23.19%99.18M	14.49%153.23M	60.61%80.51M	-4.71%133.83M	-2.28%50.13M	20.54%140.45M	-20.72%51.29M
Earning after tax	22.43%232.67M	3.29%102.44M	24.03%190.05M	23.19%99.18M	14.49%153.23M	60.61%80.51M	-4.71%133.83M	-2.28%50.13M	20.54%140.45M	-20.72%51.29M
Minority profit	844.66%13.89M	387.35%3.91M	42.24%-1.87M	-45,433.33%-1.36M	-252.31%-3.23M	100.42%3K	184.29%2.12M	-203.92%-716K	48.00%-2.52M	125.59%689K
Profit attributable to shareholders	14.00%218.79M	-2.00%98.53M	22.66%191.91M	24.89%100.54M	18.79%156.46M	58.34%80.5M	-7.87%131.71M	0.47%50.84M	17.80%142.96M	-24.91%50.61M
Basic earnings per share	14.55%1.26	-1.72%0.57	19.57%1.1	20.83%0.58	16.46%0.92	54.84%0.48	-8.14%0.79	3.33%0.31	17.81%0.86	-26.83%0.3
Diluted earnings per share	14.55%1.26	-1.72%0.57	19.57%1.1	23.40%0.58	17.95%0.92	56.67%0.47	-9.30%0.78	0.00%0.3	17.81%0.86	-26.83%0.3
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS
Audit Opinions	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--
Auditor	KPMG Huazhen Certified Public Accountants (Special General Partnership)	--	KPMG Huazhen Certified Public Accountants (Special General Partnership)	--	KPMG Huazhen Certified Public Accountants (Special General Partnership)	--	Lixin Certified Public Accountants (Special General Partnership)	--	Lixin Certified Public Accountants (Special General Partnership)	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"